Structural insights into Nirmatrelvir (PF-07321332)-3C-like SARS-CoV-2 protease complexation: a ligand Gaussian...

Area of Science:

• Molecular biology
• Biochemistry
• Drug discovery

Background:

• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes COVID-19.
• The viral 3C-like protease (3CLpro) is crucial for SARS-CoV-2 replication and serves as a key target for antiviral drug development.
• Nirmatrelvir (PF-07321332) is an orally administered competitive inhibitor investigated for COVID-19 treatment, but its precise binding mechanisms with 3CLpro are not fully understood.

Purpose of the Study:

• To elucidate the molecular binding mechanisms between Nirmatrelvir and the SARS-CoV-2 3CLpro.
• To determine the binding and dissociation rate constants (k_on and k_off) for the 3CLpro-Nirmatrelvir complex.
• To provide insights into the rational design of small-molecule antiviral drugs.

Main Methods:

• Ligand Gaussian accelerated molecular dynamics simulations.
• One-dimensional and two-dimensional potential of mean force calculations.
• Standard molecular dynamics and Kramers' rate theory.

Main Results:

• The study successfully determined the binding (k_on) and dissociation (k_off) rate constants for the interaction between 3CLpro and Nirmatrelvir.
• Quantitative insights into the dynamics of Nirmatrelvir binding to the 3CLpro active site were obtained.
• The computational approach provided a detailed understanding of the inhibitor-target complex stability.

Conclusions:

• The determined binding and dissociation rates offer crucial data for understanding Nirmatrelvir's efficacy.
• This research contributes to overcoming challenges in designing effective small-molecule antiviral therapies.
• The employed computational methods can be applied to future antiviral drug discovery efforts targeting viral proteases.